Recent Finacing
Recent Raise
BioEclipse Therapeutics is a clinical-stage biopharmaceutical company developing CRX-100, a patented, first-in-class intravenously delivered targeted immunotherapy for solid tumors, including certain rare pediatric cancers, entering Phase 1b/2a trials.
